Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Oncology

Journal Scan / Research · April 23, 2015

Chlorambucil Plus Ofatumumab vs Chlorambucil Alone in Untreated Patients With CLL

The Lancet

 

Additional Info

The Lancet
Chlorambucil Plus Ofatumumab Versus Chlorambucil Alone in Previously Untreated Patients With Chronic Lymphocytic Leukaemia (COMPLEMENT 1): A Randomised, Multicentre, Open-Label Phase 3 Trial
Lancet 2015 Apr 13;[EPub Ahead of Print], P Hillmen, T Robak, A Janssens, KG Babu, J Kloczko, S Grosicki, M Doubek, P Panagiotidis, E Kimby, A Schuh, AR Pettitt, T Boyd, M Montillo, IV Gupta, O Wright, I Dixon, JL Carey, CN Chang, S Lisby, A McKeown, F Offner

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading